Compounding Pharmacies Market: Growth, Trends, and Opportunities

The global compounding pharmacies market was valued at USD 12.67 Billion in 2024 and is projected to reach USD 21.32 Billion by 2033, growing at a CAGR of 5.7% from 2025 to 2033. The increasing demand for personalized medicine and the rising need to address drug shortages are driving the market. Compounding pharmacies specialize in preparing customized pharmaceuticals tailored to individual patient needs, including drugs that are discontinued, in limited availability, or not commercially accessible.

📥 Download Sample

Market Growth Drivers

Increasing Demand for Personalized Medicine: Personalized medicine customizes treatment based on a patient’s genetics, medical history, allergies, or preferences, improving safety, efficacy, and compliance. Compounding pharmacies can prepare bioidentical hormone replacement therapy, transdermal pain creams, and other personalized formulations. In 2016, the Personalized Medicine Coalition reported that 20% of new molecular entities approved by the FDA were customized drugs, highlighting the growing importance of personalized therapies.

Drug Shortages: Global drug shortages affect access to essential medications. Compounding pharmacies mitigate this challenge by producing medications not readily available, such as discontinued drugs or those in high demand. During the COVID-19 pandemic, compounded hydroxychloroquine was used to address supply gaps. Reports indicate 163 pharmaceuticals experienced shortages between 2013 and 2017, emphasizing the critical role of compounding pharmacies.

Market Restraints

Lack of Skilled Technicians and Pharmacists: Compounding requires high expertise. A shortage of trained lab technicians and pharmacists, especially in developed regions, limits market growth and the ability to meet patient demands.

Market Opportunities

Growing Drug Failure Rate: Developing new drugs is costly and risky. Only 12% of molecular entities in clinical trials gain FDA approval, creating an opportunity for compounding pharmacies to produce viable drugs in limited quantities under clinician guidance.

Regional Insights

North America Dominates: North America holds the largest market share due to high demand for personalized medicine, a significant geriatric population, chronic disease prevalence, drug shortages, and strong regulatory frameworks. The U.S. leads with favorable FDA regulations classifying compounding pharmacies as 503A or 503B.

Asia-Pacific: Fastest Growing Region: Rapid healthcare development, urbanization, rising disposable incomes, and an aging population drive growth. By 2050, the elderly population in Asia-Pacific is projected to reach 1.3 billion, doubling from 630 million in 2020. Key markets include China, India, and Japan.

Market Segmentation

By Dosage Forms: Solid oral preparations dominate due to convenience, precise dosing, high adherence, and patient comfort.
By Therapeutic Area: Hormone replacement, dermatology, pain management, specialty drugs, and nutritional supplements are key focus areas, allowing tailored formulations for patients with allergies or specific health requirements.
By Compounding Type:Pharmaceutical Ingredient Alteration (PIA) leads, enabling modification of active or inactive ingredients to suit individual patient needs.
By End-User: The adult population is the largest consumer, especially for topical dermatological preparations and nutritional supplements.

Key Players

• PharMEDium Services

• Fagron

• Wedgewood Pharmacy

• Fresenius Kabi

• Institutional Pharmacy Solutions

Recent Developments

• September 2023: LO3 Capital invested in Empower Pharmacy to support growth capital. Empower provides services to over 15,000 prescribers and 2,000 institutions across the U.S.

• October 2023: CurifyLabs introduced Pharma Inks adhering to GMP standards for on-site patient-specific medicine manufacturing.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/